MBF Therapeutics
Developer of an integrated immune-intelligence platform for animal vaccine research that links standardized in vitro assays, deep immunoprofiling, and in vivo challenge studies to generate longitudinal, machine-learning-ready datasets and train predictive immunology models.
Industries
Nr. of Employees
small (1-50)
Patents
Alphaherpesvirus glycoprotein d-encoding nucleic acid constructs and methods
US-11130787-B2
View Details
Alphaherpesvirus glycoprotein d-encoding nucleic acid constructs and methods
US-11130787-B2
View DetailsProducts
Immune intelligence platform for animal vaccine R&D
An integrated experimental and data platform that combines antigen design, deep immunoprofiling, nanoparticle delivery, and ML-ready data curation to support predictive model development and vaccine candidate optimization.
T-Max™ DNA T Cell Vaccine Platform
A proprietary DNA vaccine platform that identifies clinically relevant pathogen antigens and delivers them in proprietary formulations to stimulate durable and potent T cell immune responses, including universal vaccines with cross-protection.
Tmax
A veterinary DNA vaccine platform developed by MBF Therapeutics designed for efficient delivery and enhanced immune response in animals.
COVE-001
A next-generation SARS CoV-2 vaccine candidate developed by MBF Therapeutics focusing on DNA-based vaccines that elicit potent T-cell responses to conserved antigens for broad-spectrum protection.
CaptaVax™ nanoparticle delivery system
A proprietary biodegradable, immunologically inert, non-viral nanoparticle delivery system targeting gene delivery to dendritic and other antigen presenting cells, allowing safe and efficient re-administration.
canine melanoma vaccine
A personalized, alternative strategy for the prevention and treatment of melanoma in dogs, developed through a collaboration between The Wistar Institute and Man’s Best Friend Therapeutics.
Immune intelligence platform for animal vaccine R&D
An integrated experimental and data platform that combines antigen design, deep immunoprofiling, nanoparticle delivery, and ML-ready data curation to support predictive model development and vaccine candidate optimization.
T-Max™ DNA T Cell Vaccine Platform
A proprietary DNA vaccine platform that identifies clinically relevant pathogen antigens and delivers them in proprietary formulations to stimulate durable and potent T cell immune responses, including universal vaccines with cross-protection.
Tmax
A veterinary DNA vaccine platform developed by MBF Therapeutics designed for efficient delivery and enhanced immune response in animals.
COVE-001
A next-generation SARS CoV-2 vaccine candidate developed by MBF Therapeutics focusing on DNA-based vaccines that elicit potent T-cell responses to conserved antigens for broad-spectrum protection.
CaptaVax™ nanoparticle delivery system
A proprietary biodegradable, immunologically inert, non-viral nanoparticle delivery system targeting gene delivery to dendritic and other antigen presenting cells, allowing safe and efficient re-administration.
canine melanoma vaccine
A personalized, alternative strategy for the prevention and treatment of melanoma in dogs, developed through a collaboration between The Wistar Institute and Man’s Best Friend Therapeutics.
Services
End-to-end vaccine research service that integrates in vitro antigen screening, antigen construct production, nanoparticle formulation, in vivo testing, and standardized metadata capture to generate ML-ready immune datasets.
End-to-end vaccine research service that integrates in vitro antigen screening, antigen construct production, nanoparticle formulation, in vivo testing, and standardized metadata capture to generate ML-ready immune datasets.
Expertise Areas
- Veterinary vaccine development
- Immunoprofiling and immune-repertoire analysis
- Preclinical study design and challenge models
- Antigen discovery and optimization
Key Technologies
- Machine learning / foundation-model training
- TCR and BCR repertoire profiling
- Cytokine and cellular profiling
- Calcium phosphate nanoparticle delivery